Vascular development analysis: a study for tertiary anti-vascular endothelial growth factor therapy after second reactivation of retinopathy of prematurity

PurposeTo observe the vascular development results of tertiary anti-vascular endothelial growth factor (anti-VEGF) therapy following spontaneous second reactivation of retinopathy of prematurity (ROP).MethodsThis retrospective study included 22 infants (42 eyes) with Type 1 or aggressive ROP (A-ROP)...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Xuerui Zhang, Jie Peng, Yuan Yang, Yongqing Liu, Wenting Zhang, Victoria Y. Gu, Huanyu Liu, Haodong Xiao, Jiawei Yin, Yu Xu, Peiquan Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Subjects:	anti-vascular endothelial growth factor (anti-VEGF) tertiary anti-VEGF therapy reactivation vascular development analysis second reactivation retinopathy of prematurity (ROP)
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1421894/full